Sequential CAR T-Cell Therapy After Autologous Stem Cell Transplantation for the Treatment of Relapsed/Refractory Intravascular Large B-Cell Lymphoma With Central Nervous System Involvement: A Case Report

Sequential CAR T-Cell Therapy After Autologous Stem Cell Transplantation for the Treatment of Relapsed/Refractory Intravascular Large B-Cell Lymphoma With Central Nervous System Involvement: A Case Report

BackgroundIntravascular large B-cell lymphoma (IVLBCL) is a rare, aggressive, large B-cell non-Hodgkin’s lymphoma. The prognosis of IVLBCL in patients with central nervous system recurrence after first-line chemotherapy treatment is extremely poor. Among immunotherapies, chimeric antigen receptor (C...

Full description

Bibliographic Details
Main Authors: Wanying Liu, Chunrui Li, Yang Cao, Na Wang, Liang Huang, Zhen Shang, Jue Wang, Lifang Huang, Jinhuan Xu, Min Xiao, Yicheng Zhang, Jianfeng Zhou, Liting Chen, Yi Xiao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Oncology
Subjects:
CAR T-cell therapy
IVLBCL
CNS involvement
B-cell lymphoma
intravascular
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.817969/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.817969/full

Similar Items